Published in Ann Rheum Dis on November 29, 2007
Novel Methods for Ascertainment of Gout Flares -A Pilot Study | NCT02855437
Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open (2013) 1.17
Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study. BMC Med Res Methodol (2011) 0.99
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol (2011) 0.92
Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas (2010) 0.91
Gout. Novel therapies for treatment of gout and hyperuricemia. Arthritis Res Ther (2009) 0.90
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis (2011) 0.87
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol (2011) 0.87
The diagnostic value of the proposal for clinical gout diagnosis (CGD). Clin Rheumatol (2011) 0.86
Outcome measures in acute gout: a systematic literature review. J Rheumatol (2013) 0.79
Development and First Validation of a Disease Activity Score for Gout. Arthritis Care Res (Hoboken) (2016) 0.76
Utility of the Morisky Medication Adherence Scale in gout: a prospective study. Patient Prefer Adherence (2016) 0.75
Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatology (Oxford) (2016) 0.75
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med (1987) 14.37
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol (1998) 7.43
Cyclooxygenase in biology and disease. FASEB J (1998) 7.17
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 4.44
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
Detection of sickle cell anaemia and thalassaemias. Nature (1987) 3.94
Randomized clinical trial comparing loop ileostomy and loop transverse colostomy for faecal diversion following total mesorectal excision. Br J Surg (2002) 3.81
The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis (2005) 3.53
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis (2008) 3.52
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Ann Rheum Dis (2008) 3.45
Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensus. Rheumatology (Oxford) (2004) 3.38
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum (1994) 3.15
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A (1998) 3.14
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Long-term outcome after tibial shaft fracture: is malunion important? J Bone Joint Surg Am (2002) 2.92
Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ (2002) 2.90
Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med (1994) 2.89
Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review. Ann Rheum Dis (2005) 2.88
Importance of placement of intra-articular steroid injections. BMJ (1993) 2.77
Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis (1998) 2.77
Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol (1998) 2.77
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis (2009) 2.76
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75
Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Ann Rheum Dis (1999) 2.75
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol (1993) 2.74
Towards a mechanism-based classification of pain? Pain (1998) 2.73
The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol Cell Biol (1994) 2.71
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70
The Brighton resuscitation ambulances: a continuing experiment in prehospital care by ambulance staff. Br Med J (1976) 2.66
CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun (2000) 2.66
Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis (2004) 2.64
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol (1998) 2.50
Yoga-based intervention for carpal tunnel syndrome: a randomized trial. JAMA (1998) 2.50
Is it mandatory to examine synovial fluids promptly after arthrocentesis? Arthritis Rheum (1989) 2.49
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol (2004) 2.47
Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure (1996) 2.46
Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med (1987) 2.44
Screening for pain in knee osteoarthritis: which question? Ann Rheum Dis (1996) 2.41
Osteoarthritis of the knee: isokinetic quadriceps exercise versus an educational intervention. Arch Phys Med Rehabil (1999) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis (1993) 2.38
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res (1999) 2.37
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Ann Rheum Dis (2008) 2.35
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
Acute gouty arthritis is seasonal. J Rheumatol (1998) 2.29
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis (2009) 2.29
Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science (1999) 2.25
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 2.24
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis (2012) 2.20
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis (2008) 2.19
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis (2008) 2.15
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14
Calcium apatite crystals in synovial fluid rice bodies. Ann Rheum Dis (2002) 2.14
Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum (1992) 2.14
Arthroscopic lavage of osteoarthritic knees. J Bone Joint Surg Br (1991) 2.13
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore) (1999) 2.11
Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. BMJ (2000) 2.09
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis (2005) 2.08
Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis (2004) 2.08
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis (2011) 2.06
Diagnosis of gout by ultrasound. Rheumatology (Oxford) (2007) 2.05
The purification and characterization of O-acetylserine sulfhydrylase-A from Salmonella typhimurium. J Biol Chem (1969) 2.04
Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum (1973) 2.03
Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis (1995) 2.02
The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage (2006) 2.01
Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis (1998) 2.01